By identifying the critical role the urea cycle plays in its development, his findings could pave the way for new medications to treat this currently incurable disease. In a study recently ...

Camp4 Therapeutics is seeking $75 million in its IPO to advance clinical-stage programs. Learn more about CAMP stock and ...

By identifying the critical role the urea cycle plays in its development, his findings could pave the way for new medications to treat this currently incurable disease. In a study recently published ...

BioMarin is adding kindling to the R&D fire, striking a match with CAMP4 Therapeutics for rights to select two targets ...

Younger colon cancer patients had higher levels of metabolites associated with the production and metabolism of an amino acid called arginine, and with the urea cycle compared to their older peers.

Sandra A. Banta-Wright, MN, RNC, NNP; Robert D. Steiner, MD Neonates with profound and prolonged hyperammonemia with coma due to urea cycle defect will have had a neurological insult to the brain ...

Camp4 Therapeutics Inc., a Cambridge biotech that has already struck deals with Biogen Inc. and Alnylam Pharmaceuticals Inc., ...

Jack Faris interviews PNRI's brilliant scientists to uncover what excites them about genetic research, what inspired their ...

Researchers have identified a novel therapeutic target for Alzheimer’s disease by focusing on astrocytes, non-neuronal brain cells involved in waste removal.

We are also investigating gene-nutrient interactions in biochemical genetic disorders like the urea cycle disorders and maple syrup urine disease. By understanding how single gene disorders cause ...

Jason Butler, an analyst from JMP Securities, has initiated a new Buy rating on Zevra Therapeutics (ZVRA). Jason Butler has given his Buy ...

By identifying the critical role the urea cycle plays in its development, his findings could pave the way for new medications to treat this currently incurable disease. In a study recently ...